In: Yinxing H, editor
IwadateDSatoKKanzakiMKomiyamaCWatanabeCEguchiTet al
For each pulldown or binding assay, 1 mg of lysate or 1 g of recombinant YBX1HA protein was diluted in the reaction buffer containing protease inhibitor (APExBIO, 1007), RNaseOUT recombinant ribonuclease inhibitor (Invitrogen, 10777019) and 260 l of 2 TENT buffer (20 mM Tris-HCl pH 8.0, 2 mM EDTA, 500 mM NaCl and 1% v/v Triton X-100) and polysome extraction buffer (20 mM Tris-HCl pH 7.5, 100 mM KCl, 5 mM MgCl 2 and 0.5% NP-40) in a final volume of 520 l
Short-term BSO withdrawal effect on in vitro hepatocyte epigenetic modifying enzymes genes, vitamin D metabolism genes and genes associated NAFLD Treatment with BSO for 12 h showed a decline in GSH with an increased in ROS, whereas withdrawal of treatment for a period of 6 h and 12 h replenished the GSH content and decreased ROS in hepatocytes (Fig
Other studies have developed antibodies with high affinity for SLC1A5, which induce antibody-dependent cellular toxicity in gastric cancer models 204
E.GreigA